BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 3939170)

  • 21. Immune cell function and recycling of purines.
    Giblett ER
    N Engl J Med; 1976 Dec; 295(24):1375-6. PubMed ID: 824556
    [No Abstract]   [Full Text] [Related]  

  • 22. Nucleotide metabolism in cultured T cells and in cells of patients deficient in adenosine deaminase and purine nucleoside phosphorylase.
    Cohen A; Gudas LJ; Ullman B; Martin DW
    Ciba Found Symp; 1978; (68):101-14. PubMed ID: 115659
    [No Abstract]   [Full Text] [Related]  

  • 23. [Molecular pathology of immunological deficiency. Apropos of adenosine deaminase deficiency and nucleoside phosphorylase deficiency].
    Souillet G
    Pediatrie; 1975; 30(7):746-56. PubMed ID: 1105387
    [No Abstract]   [Full Text] [Related]  

  • 24. Immune deficiency due to adenosine deaminase and purine nucleoside phosphorylase deficiency: a simple diagnostic test.
    Maddocks JL; Al-Safi SA; Wilson G
    J Clin Pathol; 1984 Nov; 37(11):1305-7. PubMed ID: 6438186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purine metabolism and immunodeficiency: urinary purine excretion as a diagnostic screening test in adenosine deaminase and purine nucleoside phosphorylase deficiency.
    Simmonds HA; Sahota A; Potter CF; Cameron JS
    Clin Sci Mol Med; 1978 May; 54(5):579-84. PubMed ID: 108044
    [No Abstract]   [Full Text] [Related]  

  • 26. Absence of oroticaciduria in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency.
    Simmonds HA; Potter CF; Sahota A; Cameron JS; Webster DR; Becroft DM
    Clin Exp Immunol; 1978 Oct; 34(1):42-5. PubMed ID: 108039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immune insufficiency in enzyme defects of purine metabolism].
    Müller G
    Z Gesamte Inn Med; 1983 Feb; 38(3):83-9. PubMed ID: 6303005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s).
    Carson DA; Kaye J; Seegmiller JE
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5677-81. PubMed ID: 202960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partial deficiency of purine nucleoside phosphorylase: studies of purine and pyrimidine metabolism.
    Edwards NL; Gelfand EW; Biggar D; Fox IH
    J Lab Clin Med; 1978 May; 91(5):736-49. PubMed ID: 417142
    [No Abstract]   [Full Text] [Related]  

  • 30. Deoxyribonucleoside toxicity in adenosine deaminase and purine nucleoside phosphorylase deficiency: implications for the development of new immunosuppressive agents.
    Carson DA; Kaye J
    Ciba Found Symp; 1978; (68):115-33. PubMed ID: 115660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Adenosine deaminase deficit in severe combined immunodeficiency (author's transl)].
    Español Borén T; Jacques Castro G; Torán Fuentes N; Vives-Corrons JL
    Sangre (Barc); 1981; 26(6):1129-38. PubMed ID: 6805082
    [No Abstract]   [Full Text] [Related]  

  • 32. Characterization of a cell culture model for the study of adenosine deaminase- and purine nucleoside phosphorylase-deficient immunologic disease.
    Ullman B; Cohen A; Martin DW
    Cell; 1976 Oct; 9(2):205-11. PubMed ID: 184961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical basis for lymphocyte dysfunction in adenosine deaminase and purine nucleoside phosphorylase deficiencies.
    Carson DA; Wasson DB; Lakow E; Kamatani N
    Adv Exp Med Biol; 1984; 165 Pt B():133-9. PubMed ID: 6426261
    [No Abstract]   [Full Text] [Related]  

  • 34. [Adenosine deaminase and nucleoside phosphorylase: a new approach to the etiopathogenesis of various immunologic deficiencies].
    Lucivero G; Dammacco F; Bonomo L
    Recenti Prog Med; 1977 Sep; 63(3):275-88. PubMed ID: 413174
    [No Abstract]   [Full Text] [Related]  

  • 35. Purine metabolism in cultured human fibroblasts derived from patients deficient in hypoxanthine phosphoribosyltransferase, purine nucleoside phosphorylase, or adenosine deaminase.
    Thompson LF; Willis RC; Stoop JW; Seegmiller JE
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3722-6. PubMed ID: 99741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapy in adenosine deaminase and purine nucleoside phosphorylase deficient patients.
    Zegers BJ; Stoop JW
    Clin Biochem; 1983 Feb; 16(1):43-7. PubMed ID: 6407780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purinogenic immunodeficiency diseases: clinical features and molecular mechanisms.
    Mitchell BS; Kelley WN
    Ann Intern Med; 1980 Jun; 92(6):826-31. PubMed ID: 6247948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase.
    Carson DA; Wasson DB; Lakow E; Kamatani N
    Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3848-52. PubMed ID: 6808516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First trimester diagnosis of adenosine deaminase deficiency.
    Dooley T; Fairbanks LD; Simmonds HA; Rodeck CH; Nicolaides KH; Soothill PW; Stewart P; Morgan G; Levinsky RJ
    Prenat Diagn; 1987 Oct; 7(8):561-5. PubMed ID: 3120171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Familial immune deficit and genetic deficiency of adenosine deaminase or of nucleoside phosphorylase (author's transl)].
    Gajdos A
    Nouv Presse Med; 1978 Mar; 7(11):929-34. PubMed ID: 306093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.